Cohance Lifesciences Limited
COHANCE
Pozycja w akcjach
#6395
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Cena akcji
$5.05
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$1.93B
Zmiana (1 dzień)
-1.44%
Zmiana (1 rok)
-57.38%
Kraj
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategoria
Healthcare
Wskaźnik P/B dla Cohance Lifesciences Limited (COHANCE)
Wskaźnik P/B na dzień October 2026 TTM: 22.54
Według najnowszych raportów finansowych i ceny akcji Cohance Lifesciences Limited, obecny wskaźnik P/B (TTM) wynosi 22.54. Na koniec 2024 wynosił 8.31.
Historia wskaźnika P/B dla Cohance Lifesciences Limited od 2019 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
